Browsing Tag
Celyad Oncology
1 post
Belgium’s Celyad Oncology halts drug research as cash runs thin—will patents be enough?
Celyad Oncology ends R&D to conserve cash and pivot toward IP licensing. Find out why the Belgian biotech is betting on patents to stay afloat.